CTHRC1 and malignant colon neoplasm: As shown in Figure 3A, the OS rates of colon cancer patients with high CTHRC1 expression were significantly lower than those of colon cancer patients with low CTHRC1 expression (P ═ 0.035); similarly, a consistent trend was observed in thyroid cancer patients (P ═ 0.020) (Figure 3B).